On July 8th, 2013, The American Society of Clinical Oncology (ASCO) released new guidelines recommending the horomonal therapy medicine Aromasin to lower the breast cancer risk in postmenopausal women who are considered at high-risk of developing the disease. This is big news in the breast cancer world. What and why, you wonder? Well, I thought… Continue reading New ASCO Guidelines Recommending Aromasin to Lower Risk of Breast Cancer in High-Risk Postmenopausal Women
